Buffalo.edu uses cookies to help build a better website experience for our visitors. Learn more in our Privacy Policy.
From discovery to startup—advancing UB innovation through faculty founders.
Some of the region’s most successful companies began as startups created by UB faculty to accelerate the impact of their own discoveries. We partner with researchers every step of the way to help take your innovation to market, from launching a spinout with intellectual property protection, funding and lab space to connecting faculty founders with potential investors and customers.
Our Technology Transfer office helps UB researchers protect the novel methods, materials or software and explore commercial application via a researcher-led startup. We’ll help connect you with opportunities ranging from material transfer and confidentiality agreements to research collaborations and licensing agreements.
Funding is available for faculty to strengthen innovations for licensing, industry partnerships or launch as investible startups. Collaborative research and development grants support faculty researcher spinouts pursuing promising discoveries in life sciences, materials and manufacturing.
UB BEP partners with National Science Foundation (NSF) Innovation Corps (I-Corps) to offer immersive training programs that enable scientists, engineers and inventors to accelerate academic research projects toward commercialization for broader economic and societal benefits. Courses cover entrepreneurial essentials to take innovations to market, including customer discovery and exploring a viable product-market fit.
Not ready to launch your own company? That's ok. We can connect you with established industry partners interested in working with UB researchers to commercialize and accelerate your innovation to market.
UB boasts an impressive roster of faculty spinouts – independent businesses created to commercialize their research and bring a new product or technology to market. Meet some of the faculty spinout companies we've supported.
This UB biopharmaceutical spinout is pioneering a novel drug class aimed at preventing the delivery of anticancer toxins to healthy cells.
UB spinout advancing AI-powered hearing test to help older adults thwart cognitive decline and Alzheimer’s disease.
Technology invented at UB was licensed to develop an injected contrast agent that’s effective for radiologists and safer for patients undergoing Magnetic Resonance Imaging (MRI).
Utilizing an AI/machine learning-powered software platform, this UB spinout transforms materials discovery, streamlines production and drives sustainability.
This UB spinout is developing a low-cost blood test to screen high-risk patients for intracranial brain aneurysms.
Innovative therapies developed at UB target devastating diseases like cancer with continued funding support and incubator lab space.
Now preparing for FDA de novo submission, this UB spinout uses AI-enabled technology to guide brain surgeons and improve patient survival.
With applications in manufacturing and beyond, UB spinout TouchTronix develops sensing technology for robotic hands to help solve soaring labor costs and worker shortages.
Build your business and connect with a diverse network of entrepreneurs in our two business incubators—the Incubator @ CBLS downtown and the Incubator @ Baird near North Campus.
Get up to $100,000 in pre-seed startup capital and help from experienced entrepreneurs through the UB Cultivator.
Tap into legal services at our Entrepreneurship Law Center if you're not ready to engage outside counsel, but still need quality legal guidance.